KENNETH MCCLAIN to Vinblastine
This is a "connection" page, showing publications KENNETH MCCLAIN has written about Vinblastine.
Connection Strength
0.561
-
Drug therapy for the treatment of Langerhans cell histiocytosis. Expert Opin Pharmacother. 2005 Nov; 6(14):2435-41.
Score: 0.240
-
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013 Jun 20; 121(25):5006-14.
Score: 0.101
-
Optimal therapy for adults with Langerhans cell histiocytosis bone lesions. PLoS One. 2012; 7(8):e43257.
Score: 0.096
-
EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH. Pediatr Blood Cancer. 2008 Mar; 50(3):728-30.
Score: 0.070
-
Up-front therapy for LCH: is it time to test an alternative to vinblastine/prednisone? Br J Haematol. 2015 Apr; 169(2):299-301.
Score: 0.028
-
Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota. Am J Pediatr Hematol Oncol. 1990; 12(2):147-54.
Score: 0.020
-
Hodgkin's disease associated with central pontine myelinolysis. Med Pediatr Oncol. 1993; 21(4):311-4.
Score: 0.006